Liao Z, Gao R, Wang W, Ye Z, Lai X-W, Wang X-T, Hu L-H, Li Z-S
Chronic Pancreatic Study Group, Department of Gastroenterology, Changhai Hospital, Second Military Medical University, Shanghai, China.
Endoscopy. 2009 May;41(5):439-44. doi: 10.1055/s-0029-1214505. Epub 2009 Mar 31.
The rates for endoscopic detection of pancreas divisum at routine endoscopic retrograde cholangiopancreatography (ERCP) vary worldwide, and the sample sizes in the reported studies on endoscopy and surgery for pancreas divisum are very small and variable. The aim of this study was to systematically analyze the pooled data and determine endoscopic detection rates for pancreas divisum and pain relief rates in patients with pancreas divisum after endotherapy or surgery.
A search for published data was performed by using the Medline database (1950 to 1st May 2008) with "pancreas divisum" as the keyword. Publications, mainly on endoscopic detection rate, endotherapy, or surgery for pancreas divisum, were deemed relevant, and were further fully reviewed and analyzed.
A total of 615 abstracts were retrieved from Medline; 17 articles on endoscopic detection rate, 15 articles on endotherapy, and 13 articles on surgery were included in the review and analysis. The overall endoscopic detection rate for pancreas divisum was 2.9% (899/31,413), with the rate being significantly higher in the United States (5.8%) and Europe (6.0%) than in Asia (1.5%) (both P < 0.001). The pooled overall response rates (i. e. complete and partial pain relief rates after treatment) to endotherapy (69.4%, 361/520) and surgery (74.9%, 203/271) were similar (P = 0.106). In addition, there were significant differences in the combined response rates (for endotherapy and for surgery) between patients with pancreas divisum of acute recurrent pancreatitis (ARP)-type (81.2 %) compared with chronic pancreatitis-type (68.8%), and between ARP-type and pain-type (53.1%) (both P < 0.05).
The endoscopic detection rate for pancreas divisum is much higher in western countries than in Asian countries. The pooled response rates of patients with pancreas divisum to endotherapy and surgery are similar in the reported series. Patients with ARP-type pancreas divisum respond better to endotherapy or surgery than those with chronic pancreatitis-type and pain-type.
在常规内镜逆行胰胆管造影(ERCP)检查中,胰腺分裂症的内镜检出率在全球范围内存在差异,且已报道的关于胰腺分裂症内镜检查和手术治疗的研究样本量非常小且各不相同。本研究的目的是系统分析汇总数据,确定胰腺分裂症的内镜检出率以及内镜治疗或手术后胰腺分裂症患者的疼痛缓解率。
以“胰腺分裂症”为关键词,利用Medline数据库(1950年至2008年5月1日)检索已发表的数据。主要关于胰腺分裂症内镜检出率、内镜治疗或手术治疗的出版物被视为相关文献,并对其进行进一步全面审查和分析。
从Medline数据库共检索到615篇摘要;其中17篇关于内镜检出率、15篇关于内镜治疗、13篇关于手术治疗的文章被纳入综述和分析。胰腺分裂症的总体内镜检出率为2.9%(899/31413),美国(5.8%)和欧洲(6.0%)的检出率显著高于亚洲(1.5%)(P均<0.001)。内镜治疗(69.4%,361/520)和手术治疗(74.9%,203/271)的总体合并缓解率(即治疗后完全和部分疼痛缓解率)相似(P = 0.106)。此外,急性复发性胰腺炎(ARP)型胰腺分裂症患者与慢性胰腺炎型患者相比,以及ARP型与疼痛型患者相比,内镜治疗和手术治疗的合并缓解率存在显著差异(均为P < 0.05)。
西方国家胰腺分裂症的内镜检出率远高于亚洲国家。在已报道的系列研究中,胰腺分裂症患者内镜治疗和手术治疗的合并缓解率相似。ARP型胰腺分裂症患者内镜治疗或手术治疗的反应比慢性胰腺炎型和疼痛型患者更好些。